Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if eniluracil/5-FU/leucovorin in metastatic breast
cancer (MBC) may have efficacy and tolerability advantages over capecitabine monotherapy.